VNRX News and Press, VolitionRX Limited From 03/29/22

Heska Corporation Signs Exclusive Agreement to Introduce Nu.Q® Vet Cancer Screening Test, First-Ever Point of Care Cancer Screen PR Newswire LOVELAND, Colo. , March 29, 2022 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA) ("Heska"), a leading global...

VolitionRx Limited Schedules Full Fiscal Year 2021 Earnings Conference Call and Business Update PR Newswire Conference call to take place on Thursday March 31 at 08:00a.m. Eastern time AUSTIN, Texas , March 28, 2022 /PRNewswire/ -- VolitionRx Limi...

NEW YORK, March 14, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the March 10 th Life Sciences Investor Forum are now available for on-demand viewing. REGISTER OR LOGIN NOW ...

NEW YORK, March 08, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the upcoming Life Sciences Investor Forum on March 10 th . This virtual event will showcase live company presentations and intera...

NEW YORK, March 07, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the upcoming Life Sciences Investor Forum on March 10 th . This virtual event will showcase live company presentations and intera...

Volition presents study data at ASCO GI 2022 on circulating nucleosomes for the detection of colorectal cancer and high-risk advanced adenomas PR Newswire AUSTIN, Texas , Jan. 20, 2022 /PRNewswire/ --VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-...

VolitionRX develops and sells a simple and cost effective blood test to detect cancers and other serious diseases in our best friends, dogs. The potential market is huge, with 77 millions dogs in the U.S., and 83% of which visit a vet at lease once a year. Their test can identify ...

Volition Executes its First Supply and Licensing Contract for its Nu.Q® Vet Cancer Screening Test in Asia PR Newswire SAGE Healthcare Private Limited appointed to serve as a non-exclusive licensee and distributor for Volition's Nu.Q ® Vet Cancer Screening...

Virtual Conference for Life Sciences Companies Broadcast Live December 16th Canada NewsWire Company executives will share corporate vision and answer audience questions at VirtualInvestorConferences.com NEW YORK , Dec. 14, 2021 /CNW/ - Virtual Investor Co...

Life Sciences Virtual Investor Conference: Company Executives Present Live December 16th Company executives will share corporate vision and answer audience questions at VirtualInvestorConferences.com PR Newswire NEW YORK , Dec. 9, 2021 /PRNewswire/ -- Vi...